Clinical study of RESPIRATORY SYNCYTIAL VIRUS (RSV) in adults at high-risk due to underlying medical conditions
Latest Information Update: 05 Jun 2023
At a glance
- Drugs Respiratory syncytial virus vaccine Pfizer (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions
Most Recent Events
- 05 Jun 2023 New trial record